SLNSW-Long-term safety and activity of axicabtagene cil...-TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733402

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

Full title: Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

Author/creator: Locke, Frederick L, Ghobadi, Armin, Jacobson, Caron A, Miklos, David B, Lekakis, Lazaros J, Oluwole, Olalekan O, Lin, Yi, Braunschweig, Ira, Hill, Brian T, Timmerman, John M, Deol, Abhinav, Reagan, Patrick M, Stiff, Patrick, Flinn, Ian W, Farooq, Umar, Goy, Andre, McSweeney, Peter A, Munoz, Javier, Siddiqi, Tanya, Chavez, Julio C, Herrera, Alex F, Bartlett, Nancy L, Wiezorek, Jeffrey S, Navale, Lynn, Xue, Allen, Jiang, Yizhou, Bot, Adrian, Rossi, John M, Kim, Jenny J, Go, William Y, Neelapu, Sattva S.

Call Numbers:

Record Identifier: TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733402

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733402

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

    Record identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733402

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733402

    Share

    Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733402

    Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

    Full title

    Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

    Author / Creator

    Locke, Frederick L ; Ghobadi, Armin ; Jacobson, Caron A ; Miklos, David B ; Lekakis, Lazaros J ; Oluwole, Olalekan O ; Lin, Yi ; Braunschweig, Ira ; Hill, Brian T ; Timmerman, John M ; Deol, Abhinav ; Reagan, Patrick M ; Stiff, Patrick ; Flinn, Ian W ; Farooq, Umar ; Goy, Andre ; McSweeney, Peter A ; Munoz, Javier ; Siddiqi, Tanya ; Chavez, Julio C ; Herrera, Alex F ; Bartlett, Nancy L ; Wiezorek, Jeffrey S ; Navale, Lynn ; Xue, Allen ; Jiang, Yizhou ; Bot, Adrian ; Rossi, John M ; Kim, Jenny J ; Go, William Y ; Neelapu, Sattva S

    Publisher

    England: Elsevier Ltd

    Journal title

    The lancet oncology, 2019, Vol.20 (1), p.31-42

    Record Identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733402

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adult Aged Analysis Anthracycline Antigens Antigens, CD19 - administration & dosage Antigens, CD19 - adverse effects Antigens, CD19 - therapeutic use Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Autografts B-cell lymphoma Bacteremia Cardiac arrhythmia CD19 antigen CD20 antigen Chemotherapy Chimeric antigen receptors Cyclophosphamide Cyclophosphamide - administration & dosage Cyclophosphamide - adverse effects Cyclophosphamide - therapeutic use Cytokines Female Fludarabine Follow-Up Studies Humans Immunotherapy, Adoptive - adverse effects Intravenous administration Lymphocytes Lymphocytes B Lymphocytes T Lymphoid tissue Lymphoma Lymphoma, Follicular - mortality Lymphoma, Follicular - pathology Lymphoma, Follicular - therapy Lymphoma, Large B-Cell, Diffuse - mortality Lymphoma, Large B-Cell, Diffuse - therapy Lymphomas Male Medical prognosis Middle Aged Monoclonal antibodies Myelodysplastic syndrome Neutropenia Oncology Patients Safety Stem cell transplantation Surface area Survival Analysis Treatment Outcome Tumors Vidarabine - administration & dosage Vidarabine - adverse effects Vidarabine - analogs & derivatives Vidarabine - therapeutic use

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733402

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733402

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections